Figure 20 displays a forest plot for the network meta-analysis reporting all discontinuations in studies comparing csDMARD monotherapy with csDMARD monotherapy. One comparison was used in this analysis. Study-level data used in this Figure are presented in Appendix C. This figure is described further in the KQ3 Results section “csDMARD Monotherapy Versus csDMARD Monotherapy” as follows: “Our NWMA supported this finding with higher overall discontinuations for SSZ compared with MTX (RR, 1.83; 95% CI, 1.06 to 3.16).”

Figure 20Forest plot for network meta-analysis of all discontinuations: csDMARD monotherapy versus csDMARD monotherapy

95% CI = 95% confidence interval; csDMARD = conventional synthetic DMARD; MTX = methotrexate; RR = relative risk; vs. = versus.

From: Results

Cover of Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 211.
Donahue KE, Gartlehner G, Schulman ER, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.